Next Quarterly Earnings
Friday, October 30, 2026
CW 44
Pre-Market
In 64 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Immunovant
Immunovant is a US-based biopharmaceutical company specializing in the development of innovative therapies for autoimmune diseases. By researching novel FcRn inhibitors, the company specifically addresses serious immunological conditions through advanced clinical development and scientific innovation.
Frequently asked questions
When will Immunovant report its next quarterly earnings?
Immunovant is scheduled to report its next quarterly earnings on 10/30/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Immunovant last report quarterly earnings?
Immunovant last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.75 USD.
How often has Immunovant beaten expectations?
Immunovant has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Immunovant earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
-8.5%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Immunovant
Country
🇺🇸
More Financial Information